Pages that link to "Q84113692"
Jump to navigation
Jump to search
The following pages link to Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses (Q84113692):
Displaying 29 items.
- Intraocular and serum cytokine profiles in patients with intermediate uveitis (Q24619574) (← links)
- Interleukin-6 blockade in ocular inflammatory diseases (Q27011357) (← links)
- Roles of interleukin-17 in uveitis (Q28079126) (← links)
- IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia (Q30439206) (← links)
- Small heat shock protein αA-crystallin prevents photoreceptor degeneration in experimental autoimmune uveitis (Q34221494) (← links)
- IL-17–Dependent, IFN-γ–Independent Tumor Rejection Is Mediated by Cytotoxic T Lymphocytes and Occurs at Extraocular Sites, but Is Excluded from the Eye (Q35269684) (← links)
- Cytokines in autoimmune uveitis (Q35294461) (← links)
- Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats (Q35522151) (← links)
- Diphlorethohydroxycarmalol inhibits interleukin-6 production by regulating NF-κB, STAT5 and SOCS1 in lipopolysaccharide-stimulated RAW264.7 cells (Q35548873) (← links)
- Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation (Q35986943) (← links)
- Understanding autoimmunity in the eye: from animal models to novel therapies (Q36069863) (← links)
- Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis (Q37262587) (← links)
- IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. (Q37597431) (← links)
- IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses (Q37684639) (← links)
- IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer (Q37850186) (← links)
- Immunotherapeutic Implication of IL-6 Blockade (Q37965754) (← links)
- Uveitis in seronegative arthritis (Q38021939) (← links)
- Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases (Q38058508) (← links)
- Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases (Q38129871) (← links)
- Inhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance (Q38197519) (← links)
- Involvement of corneal epithelial cells in the Th17 response in an in vitro bacterial inflammation model. (Q39200064) (← links)
- IL-6 blockade in the management of non-infectious uveitis (Q40204739) (← links)
- Unraveling methylation changes of host macrophages in Mycobacterium tuberculosis infection. (Q40683257) (← links)
- Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody (Q41117094) (← links)
- Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism (Q41585035) (← links)
- Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis (Q45766025) (← links)
- Tocilizumab treatment for refractory uveitis-related cystoid macular edema. (Q45903627) (← links)
- Photopic light-mediated down-regulation of local α-adrenergic signaling protects blood-retina barrier in experimental autoimmune uveoretinitis (Q64263800) (← links)
- Efficacy of Tocilizumab in Two Patients with anti-TNF-alpha Refractory Uveitis (Q85039818) (← links)